TD Waterhouse Canada’s Ginkgo Bioworks DNA Stock Holding History

TD Waterhouse Canada’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$514	Hold	50	–	–	﹤0.01%	2249
2026 Q1	$339	Hold	50	–	–	﹤0.01%	2163
2025 Q4	$414	Hold	50	–	–	﹤0.01%	1915
2025 Q3	$733	Hold	50	–	–	﹤0.01%	1918
2025 Q2	$568	Hold	50	–	–	﹤0.01%	1848
2025 Q1	$283	Hold	50	–	–	﹤0.01%	1831
2024 Q4	$491	Hold	50	–	–	﹤0.01%	1829
2024 Q3	$380	Hold	50	–	–	﹤0.01%	1769
2024 Q2	$646	Hold	50	–	–	﹤0.01%	1762
2024 Q1	$2.08K	Sell	50 -25	-33%	-$1.29K	﹤0.01%	1667
2023 Q4	$4.68K	Hold	75	–	–	﹤0.01%	1386
2023 Q3	$5.13K	Hold	75	–	–	﹤0.01%	1356
2023 Q2	$5.37K	Hold	75	–	–	﹤0.01%	1373
2023 Q1	$3.81K	Hold	75	–	–	﹤0.01%	1430
2022 Q4	$4.71K	Hold	75	–	–	﹤0.01%	1357
2022 Q3	$9.36K	Hold	75	–	–	﹤0.01%	1244
2022 Q2	$7.14K	Buy	+75	New	+$9.15K	﹤0.01%	1313

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

TD Waterhouse Canada's DNA Position: Q2 2026 in Review

TD Waterhouse Canada held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 50 shares worth $514. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

TD Waterhouse Canada first reported a position in DNA in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.36K in Q3 2022. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

TD Waterhouse Canada held 50 shares of Ginkgo Bioworks worth $514 as of Q2 2026.
TD Waterhouse Canada left its Ginkgo Bioworks share count unchanged in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2249 holding.
TD Waterhouse Canada first reported a position in Ginkgo Bioworks in Q2 2022 and has held it in 17 quarters since.
TD Waterhouse Canada's Ginkgo Bioworks position peaked at $9.36K in Q3 2022.
183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.